Ketorolac ophthalmic implant - Layerbio
Alternative Names: OcuRing-K™Latest Information Update: 28 Jan 2023
At a glance
- Originator Layerbio
- Class 2 ring heterocyclic compounds; Carboxylic acids; Eye disorder therapies; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Postoperative inflammation; Postoperative pain
Most Recent Events
- 28 Jan 2023 No recent reports of development identified for phase-I development in Postoperative-inflammation in Mexico (Intraocular, Implant)
- 28 Jan 2023 No recent reports of development identified for phase-I development in Postoperative-pain in Mexico (Intraocular, Implant)
- 31 Dec 2020 Chemical structure information added